期刊文献+

倍他乐克注射液治疗急性心肌梗死疗效观察 被引量:1

Metoprolol injection in the treatment of acute myocardial infarction
下载PDF
导出
摘要 目的探讨静脉注射倍他乐克治疗急性心肌梗死的有效性及安全性。方法 33例急性心肌梗死患者,排除严重低血压、严重心动过缓、Ⅲ度房室传导阻滞及心源性休克情况,予3支倍他乐克针剂缓慢静脉注射,每支5mg,共15mg,间隔5min,观察心率、血压、心功能、ST段抬值总和、胸痛程度及1周内恶性心律失常、猝死、再发心肌梗死等情况。结果静脉注射倍他乐克后,患者血压、心率及收缩压与心率乘积(SBPHR)、胸痛积分均明显下降,而心梗相关导联ST段抬高值的总和(∑ST)也有明显下降,心功能无明显下降,1周内未发生不断改进性心律失常、猝死、再发心肌梗死。结论早期静脉注射倍他乐克可有效预防急性心肌梗死患者发生心力衰竭和预防猝死、再发心肌梗死。 Objective To study the effects of intravenous metoprolol for treatment of acute myocardial infarction in safety and efficacy.Methods 33 cases of patients with acute myocardial infarction,the exclusion of severe hypotension,severe heart beat bradycardia,atrioventricular block and cardiogenic shock,to the 3 times he le g injection slow intravenous injection,each branch of 5 mg,15 mg,5 min interval,heart rate,blood pressure,heart function,value of the sum of ST segment carried within 1 weeks,chest pain and malignant arrhythmia,sudden cardiac death,recurrent myocardial infarction;Results intravenous metoprolol g,blood pressure,heart rate and systolic blood pressure and heart rate(SBP HR product),chest pain score decreased significantly,while ST segment elevation myocardial infarction related to the sum of the values(and ST) also decreased significantly,cardiac function without obvious decline,1 weeks without improvement of arrhythmias,sudden death,recurrent myocardial infarction;Conclusion Early intravenous metoprolol for G can be effective in preventing acute myocardial infarction occurring in patients with heart failure and prevention of sudden death,recurrent myocardial infarction.
出处 《中国实用医药》 2011年第28期26-27,共2页 China Practical Medicine
关键词 倍他乐克 急性心肌梗死 治疗 Metoprolol Acute myocardial infarction Treatment
  • 相关文献

参考文献4

二级参考文献7

  • 1曲秀芬,黄永麟,纪树彦,朴晶艳,宋丽云.β受体阻滞剂对急性心肌梗死心率变异性和预后的影响(摘要)[J].临床心电学杂志,1995,4(4):168-169. 被引量:13
  • 2[1]Second Chinese Cardiac Study (CCS-2) Collaborative Group. Rational, design and organization of the Second Chinese Cardiac Study (CCS-2): A randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. J Cardiovasc Risk,2000,7:435-441.
  • 3[2]ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet,1995,345:669-685.
  • 4[3]Antman E M, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA,1992,327:248-254.
  • 5[4]The Heart Outcome Prevention Evaluation (HOPE) Study Investigator. Effects of an angiotensin-converting enzyme inhibitor ramipril on cardiovascular events in high-risk patients. N Engl J Med,2000,342:145-153.
  • 6[5]Freemantle N, Cleland J, Young P, Harrison, et al. b-blockade after myocardial infarction: Systematic review and meta regression analysis. BMJ,1999,318:1730-1737.
  • 7[6]MRc/BHF Heart Protection Study Collaborative Group. Randomized trial of cholesterol-lowering with simvastatin in a wide range of patients at increased risk of vascular disease. Lancet ,2002,360:7-22.

共引文献52

同被引文献8

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部